|
2023
|
G/S
|
Pharmaceutical preparations. |
|
2021
|
Invention
|
Tablet and method for manufacturing same.
The present invention addresses the problem of providi... |
|
|
Invention
|
Tablet and method for manufacturing same. The present invention addresses the problem of providin... |
|
2020
|
Invention
|
Orally disintegrating tablet and manufacturing method therefor. The present invention addresses t... |
|
|
Invention
|
Therapeutic agent for wolfram syndrome. [Problem] To provide a therapeutic agent for Wolfram synd... |
|
2018
|
Invention
|
6h-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivative. The 6H-thieno[2,3-e][1,2,4]tr... |
|
|
Invention
|
6h-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivatives. This 6H-thieno[2,3-e][1,2,4]... |
|
|
Invention
|
6h-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivative. This 6H-thieno[2,3-e][1,2,4]t... |
|
2017
|
Invention
|
Inhibition of il-2 production.
An object is to find a substance which inhibits IL-2 production.
... |
|
2014
|
Invention
|
3-hydroxy-6h-benzo [c] chromene-6-one derivative and manufacturing method thereof. A method of ma... |
|
|
Invention
|
Inhibition of il-2 production. IL-2 production can be inhibited by a compound represented by the ... |
|
|
Invention
|
Inhibition of il-2 production. The purpose of the present invention is to find a substance capabl... |
|
|
Invention
|
Inhibition of production of il-2. The purpose of the present invention is to find a substance cap... |
|
2012
|
Invention
|
Method for treating a trpv1-mediated disease. A method for treating a TRPV1-mediated disease by a... |
|
|
Invention
|
3-hydroxy-6h-benzo [c] chromene-6-one derivative and manufacturing method thereof. A method for p... |
|
2011
|
Invention
|
Method for treating a disease related to the glucocorticoid receptor. A method for treating a dis... |
|
|
Invention
|
Method for preventing or treating a glucocorticoid receptor-related disease. A method of preventi... |
|
2009
|
Invention
|
Pharmaceutical composition for improving intestinal absorption. 6 each represent a hydrogen atom ... |
|
|
Invention
|
Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivati... |
|
|
Invention
|
Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivat... |
|
2007
|
Invention
|
1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-i... |
|
2006
|
G/S
|
Pharmaceutical preparations; medicines for human purposes;
vitamin preparations; medicinal drink... |
|
|
Invention
|
1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity. 9 represents a h... |
|
|
Invention
|
1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity. An object ... |
|
|
Invention
|
Tnf-α production inhibitors. A purpose of the present invention is to provide TNF-α production in... |
|
|
Invention
|
Method for treating pain or pruritis by administering κ-opioid receptor agonist comprising 2-phen... |
|
2004
|
Invention
|
Inhibitor of pain threshold decrease. The invention aims to provide a drug having an activity on ... |
|
2003
|
Invention
|
Κ opioid receptor agonist comprising 2-phenylbenzothiazoline derivative. A compound or a salt the... |
|
|
Invention
|
.kappa.-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative. The present... |
|
2001
|
Invention
|
Tnf-.alpha. production inhibitors. A purpose of the present invention is to provide TNF-.a... |
|
1993
|
G/S
|
testing threads for medical purpose, particularly for tear volume testing |
|
|
G/S
|
Test threads for medical purpose, namely for testing the volume of tears in the eyes. |
